---
title: "ep-tB5SXXmd9vU @ 00:33:10"
episode: "tB5SXXmd9vU"
timestamp: 1990.96
anchor: "t-00-33-10"
---

[▶️ Watch on YouTube at 00:33:10](https://www.youtube.com/watch?v=tB5SXXmd9vU&t=1990)

[← Back to episode](/episodes/ep-tB5SXXmd9vU.md#^t-00-33-10)

## Transcript

**SPEAKER_1:**
> If they're using this construction site, it seems to me that they're doing it to buy time, because I actually know they're using it to buy time because they claim that it's construction in this article. On May 2024, they say that construction is expected to take about a year. Well, it's been over a year. It's been about two years. And by the looks of it, the entire top of that building being a skeleton tells me that it's probably going to be a few years after that as well. This is clearly not taking about a year. Also, guess who the longtime CEO of that biopharmaceutical company Incyte was? Hervé Hoppenot. And guess what? He's also French. He's not just French, but he is a French national.

## Claims Made

- [factual] the longtime CEO of that biopharmaceutical company Incyte was Hervé Hoppenot. And guess what? He's also French. He's not just French, but he is a French national. He seems to have just exited as the CEO, but he is still running the company under the role of advisor to the CEO. He is directly responsible for this construction at Bracebridge, and he was the one that finalized the deal. I find it very strange how he ran this company for more than a decade. And for some reason, just a few months before Charlie's (Charlie Kirk's) death, he decides to switch roles
  - *Follow-up:* Verify executive changes via company filings
